Restoring partial vision to a blind patient
- PMID: 35812361
- PMCID: PMC9239363
- DOI: 10.12703/r-01-0000012
Restoring partial vision to a blind patient
Abstract
This paper reports an important breakthrough in partially restoring sight to a man who had lost his vision due to retinitis pigmentosa (RP), a heritable retinal degenerative disease that affects approximately 1 in 4000 people. Long considered an insurmountable challenge, a stellar team of vision scientists, engineers, basic biologists, and others, working together for many years, has enabled a man who had been legally blind for decades to begin distinguishing objects and navigating his environment1.
Keywords: RGC; Retinitis pigmentosa; cones; retinal ganglion cells; rods.
Copyright: © 2022 Faculty Opinions Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Comment on
-
Partial recovery of visual function in a blind patient after optogenetic therapy.Nat Med. 2021 Jul;27(7):1223-1229. doi: 10.1038/s41591-021-01351-4. Epub 2021 May 24. Nat Med. 2021. PMID: 34031601
References
-
- Sahel JA, Boulanger-Scemama E, Pagot C, Arleo A, Galluppi F, Martel JN, Degli Esposti S, Delaux A, de Saint Aubert JB, de Montleau C, Gutman E, Audo I, Duebel J, Picaud S, Dalkara D, Blouin L, Taiel M, Roska B. 2021. Partial recovery of visual function in a blind patient after optogenetic therapy Nat Med 27:1223–1229. 10.1038/s41591-021-01351-4 - DOI - PubMed
-
- Sahel J, Audo I, Boulanger-Scemama E, Pagot C, Arleo A, Martel J, Esposti SD, Delaux A, de Saint Aubert JB, de Montleau C, Gutman E, Duebel J, Picaud S, Dalkara D, Taiel M, Roska B. 2022. Optogenetics in the clinic: safety and efficacy updates on the phase 1/2 clinical trial PIONEER ARVO 2022 Annual Meeting Reference Source
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources